
Would Wider Access to GLP-1s Throttle Addiction?
Cato Daily Podcast
00:00
Exploring the Off-Label Use of GLP-1 Drugs in Addiction Treatment
This chapter explores the careful approach required in using GLP-1 drugs for addiction treatment, focusing on ongoing research related to their effectiveness and safety. It also discusses off-label prescribing and its impacts on patients, emphasizing the need for further clinical trials as these medications gain traction for uses outside traditional diabetes and obesity treatment.
Transcript
Play full episode